TABLE 1.
The demographic and clinical characteristics of all subjects recruited
| aADHD (N = 69) | HC (N = 44) | t/χ 2 value | p value | |
|---|---|---|---|---|
| Age (Mean ± SD) | 25.37 ± 4.63 | 26.24 ± 3.94 | −1.03 | 0.304 |
| Sex, n (male/female) | 46/23 | 23/21 | 2.34 | 0.126 |
| FIQ (Mean ± SD) | 119.53 ± 7.90 | 120.46 ± 7.23 | −0.59 | 0.556 |
| ADHD subtypes, n (%) | ||||
| ADHD‐I | 11 (15.9) | − | − | − |
| ADHD‐C | 58 (84.1) | − | − | − |
| ADHD symptoms (Mean ± SD) | ||||
| Inattentive | 27.11 ± 4.40 | 13.60 ± 3.46 | 15.66 | <0.001 |
| Hyperactive/impulsive | 18.98 ± 5.06 | 12.40 ± 2.80 | 8.29 | <0.001 |
| Total | 46.10 ± 7.82 | 26.00 ± 5.89 | 13.25 | <0.001 |
| “Inhibit” score (Mean ± SD) | 16.91 ± 3.21 | 10.18 ± 2.08 | 11.87 | <0.001 |
aADHD, adults with attention‐deficit/hyperactivity disorder; HC, healthy controls; SD, standard deviation; FIQ, full‐scale intelligence quotient; ADHD‐I, prominently inattentive subtype; ADHD‐C, combined subtype.